Haverford Healthcare Advisors is pleased to announce its role as sell-side advisor to Metropolitan Medical Laboratories in connection with its sale to Labcorp. Haverford initiated this transaction on behalf of Metropolitan Medical Laboratories.
Labcorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, Labcorp delivers world-class diagnostics solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care.
Click here to read the full press release.